Cash-strapped governments around the world are balking at the cost of green measures.

Cherry is a freelance writer specialising in investment journalism and finance topics. She Tweets at: @creynard0654
Cash-strapped governments around the world are balking at the cost of green measures.
Emerging market growth is becoming increasingly dependent on fundamentals.
The Novo Nordisk share price is up 51% over the past year, while Eli Lilly is up 84%.
It is difficult to pick the resulting market outcome from any election.
Mega cap tech stocks led the way in 2023, but market performance widened in the final two months.
As relations between China and the US remain strained, those countries that are trying to stay clear of any friction could benefit.
There are solid arguments supporting a harder landing scenario than markets are pricing in.
Following a lacklustre set of Q3 results, are the technology stocks finally losing their sheen?
Will a rate hike pause from the ECB be enough to improve European stock market performance?
Bad news for China doesn’t have to be bad news for Asia overall.
Part of the Mark Allen Group.